Evogene Ltd.

TASE:EVGN Stock Report

Market Cap: ₪135.0m

Evogene Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Ofer Haviv

Chief executive officer

US$401.0k

Total compensation

CEO salary percentage97.3%
CEO tenure19.4yrs
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Mar 05
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Oct 09
Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Jun 26
Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Mar 13
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Here's Why We're Watching Evogene's (TLV:EVGN) Cash Burn Situation

Oct 07
Here's Why We're Watching Evogene's (TLV:EVGN) Cash Burn Situation

We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Jun 16
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Mar 02
Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Here's Why We're Not Too Worried About Evogene's (TLV:EVGN) Cash Burn Situation

May 28
Here's Why We're Not Too Worried About Evogene's (TLV:EVGN) Cash Burn Situation

Companies Like Evogene (TLV:EVGN) Are In A Position To Invest In Growth

Jan 21
Companies Like Evogene (TLV:EVGN) Are In A Position To Invest In Growth

What Can We Make Of Evogene's (TLV:EVGN) CEO Compensation?

Nov 30
What Can We Make Of Evogene's (TLV:EVGN) CEO Compensation?

CEO Compensation Analysis

How has Ofer Haviv's remuneration changed compared to Evogene's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$401kUS$390k

-US$24m

Sep 30 2023n/an/a

-US$20m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$25m

Dec 31 2022US$464kUS$415k

-US$27m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$32m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$530kUS$420k

-US$28m

Sep 30 2021n/an/a

-US$29m

Jun 30 2021n/an/a

-US$26m

Mar 31 2021n/an/a

-US$24m

Dec 31 2020US$592kUS$367k

-US$23m

Sep 30 2020n/an/a

-US$21m

Jun 30 2020n/an/a

-US$21m

Mar 31 2020n/an/a

-US$21m

Dec 31 2019US$538kUS$366k

-US$18m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$18m

Mar 31 2019n/an/a

-US$19m

Dec 31 2018US$517kUS$324k

-US$21m

Sep 30 2018n/an/a

-US$21m

Jun 30 2018n/an/a

-US$21m

Mar 31 2018n/an/a

-US$21m

Dec 31 2017US$649kUS$359k

-US$21m

Compensation vs Market: Ofer's total compensation ($USD401.00K) is about average for companies of similar size in the IL market ($USD434.82K).

Compensation vs Earnings: Ofer's compensation has been consistent with company performance over the past year.

CEO

Ofer Haviv (57 yo)

19.4yrs

Tenure

US$401,000

Compensation

Mr. Ofer Haviv, CPA, served as Interim Chief Executive Officer of Lavie Bio Ltd. since January 2023. He has been Chief Executive Officer and President of Evogene Limited since December 2004 and served as i...

Leadership Team

NamePositionTenureCompensationOwnership
Ofer Haviv
CEO & President19.4yrsUS$401.00kno data
Nir Arbel
Chief Product Officer2.8yrsUS$292.00k0%
$ 0
Brian Ember
Chief Executive Officer of AgPlenus Ltd2.4yrsUS$456.00kno data
Elran Haber
Chief Executive Officer of Biomica Ltd6.3yrsUS$339.00k0%
$ 0
Amit Noam
Chief Executive Officer of Lavie Bio Ltd.1.1yrsUS$606.00kno data
Yaron Eldad
Chief Financial Officer2.1yrsno data0%
$ 0
Mark Kapel
Chief Technology Officer6.3yrsUS$299.00k0%
$ 0
Rachel Gerber
Head of Investor Relationsless than a yearno datano data
Sassi Masliah
Vice President of Corporate Development2.3yrsUS$304.00k0%
$ 0
Liat Wejgman
Vice President of Human Resources2.3yrsno datano data
Eyal Ronen
Executive Vice President of Business Development1.9yrsno data0%
$ 0
Yoash Zohar
Chief Executive Officer of Casterra Ag Ltd.less than a yearno datano data

2.3yrs

Average Tenure

46.5yo

Average Age

Experienced Management: EVGN's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dan Falk
Independent Director2.5yrsno data0%
$ 0
Nir Nimrodi
Independent Director1.5yrsno data0%
$ 0
Leon Recanati
Independent Director19yrsno data1.66%
$ 2.2m
Sarit Firon
Independent Chairperson of the Board7.8yrsno data0%
$ 0
Oded Shoseyov
Independent Director5.5yrsno data0%
$ 0
Avraham Levy
Chairman of Scientific Advisorsno datano datano data
Adrian Percy
Independent Director5.3yrsno data0%
$ 0
Naama Barkai
Scientific Advisorno datano datano data
Eran Segal
Scientific Advisor2.3yrsno datano data

5.3yrs

Average Tenure

62.5yo

Average Age

Experienced Board: EVGN's board of directors are considered experienced (5.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.